Modernizing Medicine has closed the first tranche of a $20m round of funding for its electronic medical records system, with Pentland participating as a return investor.

Ziarco, which develops therapeutics for inflammatory skin diseases, raised $33.1m in series B funding featuring Pfizer Venture Investments and Amgen Ventures.

Tara aims to significantly reduce the costs of drug development.

Nottingham spins out biotech to commercialise research that could prevent prostate cancer.

Moving from Boulder to Tucson the spin-out is set to work closely with Arizona University.

How to be truly global in the search for your next nugget - Andrew Kelly, executive director, BioPacific Partners.

Dundee spin-out Ex Scientia signs collaboration agreement with US-based pharmaceutical Sunovion.

The biosimilar developer, backed by Eli Lilly, Daaichi Sankyo and Medpace, will use the proceeds from its initial public offering to advance three of its product candidates.